Navigation Links
Golden Meditech Announces Financial Year 2008/09 Annual Results

HONG KONG, June 30 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Company Limited ("Golden Meditech" or the "Group"; Stock Code: 801.HK), a leading hi-tech medical device and healthcare service corporation in China, today announced its annual results for the year ended 31 March 2009. During the year, the Group not only maintained stable growth in revenue of the core businesses, but also successfully listed its cord blood bank division in the U.S. Another U.S. listing of its fast-moving consumer electronics distributor and retailer, Pypo Digital Company Limited will also be completed soon. Meanwhile, Golden Meditech also made a strategic entry into China's hospital management industry so as to lay firm foundations for robust, sustainable future growth.

Being the largest blood related medical device manufacturer and the largest cord blood bank service provider in China, Golden Meditech recorded turnover in the core businesses of HK$497,756,000 representing an increase of 18% from last year. The Medical Device Segment and the Healthcare Service Segment contributed 56% and 44% to the Group's total revenue respectively. The Group's gross profit margin was maintained at 71%, which is higher than that of many industry peers.

Due to the global financial crisis, the Group recorded about HK$82,894,000 in other net losses. Excluding such one-time losses and the associate's non-cash impairment charge on certain intangibles, the Group's adjusted net profit was up 28% from the previous year. Basic earnings per share was HK3.7cents.

Mr. Kam Yuen, Chairman of Golden Meditech said, "The Medical Devices Segment broadened its products range and launched two new products namely the Plasma Exchange System and the Accelerated Thermostatic Infusion Pump. We expect the new products will become additional growth drivers for the Medical Devices Segment."

With an optimized service mix, the Healthcare Service Segment made significant progress in terms of market share and overall profitability. The segment reported strong revenue growth of the Cord Blood Bank Division during the year, with the division's total turnover increasing by 61% to HK$221,221,000. The Guangdong Cord Blood Bank reported a 221% growth in sales compared with the previous year.

Mr. Kam added, "Our cord blood bank business has stepped up the pace of its expansion plan outside China. We, through a strategic ownership of Cordlife Ltd., the largest cord blood bank operator in Southeast Asia, have become one of the world's largest cord blood bank operators in terms of population coverage. The listing in the U.S. will help the division speed up the pace of geographical expansion in China and overseas. Up to the date, it is the first Chinese healthcare enterprise listed in the U.S. this year."

He concluded, "To capture the unique opportunities brought by new medical reforms in China, the Group strategically extended its footholds in the hospital management and services industry. Synergistic effects with the existing businesses resulted and the move helped us to provide all round healthcare products and services to the Chinese public through our integrated operations. This also enhanced the Group's competitiveness in China."

Among the Group's strategic investments, Pypo Digital Company Limited, a fast-moving consumer electronics distributor and retailer, will be listed in the U.S. soon.

Golden Meditech Company Limited (the "Company" or "Golden Meditech"; stock code: 801), together with its subsidiaries (collectively referred to as the "Group"), is a leading healthcare corporation in China. Golden Meditech operates an integrated portfolio of healthcare businesses including the manufacturing of medical devices, the provision of healthcare services and the production of natural herbal medicines. It has gained dominant market positions in all business segments. The first healthcare company listed outside Mainland China, the Group debuted on the Growth Enterprise Market (GEM) of the Stock Exchange of Hong Kong in December 2001 and migrated its listing to the Main Board in June 2009. The Group's mission is to contribute to people's health and welfare through the development and generalization of advanced medical technology, and to create value for its shareholders.

    For enquiries, please contact:

     Investor relations department
     Golden Meditech Company Limited
     Address: 48/F., Bank of China Building,
              1 Garden Road, Central, Hong Kong
     Tel:     +852-3605-8138
     Fax:     +852-3605-8181

SOURCE Golden Meditech Company Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Golden Rainbow Celebrates Las Vegas Entertainment in 23rd Annual Ribbon of Life Production Show
2. WWII Veterans Compete in National Veterans Golden Age Games
3. Golden rice an effective source of vitamin A
4. Thermal Angel Supports Infection Control During the Golden Hour
5. IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting
6. Golden Meditech Releases FY2008/09 Q3 Results
7. Bellevue Hospital Faces EEOC Race Discrimination Charge, According to Outten & Golden LLP
8. Axium Healthcare Pharmacy, Inc. Has Been Chosen as One of Central Floridas Golden 100 Companies
9. Chicago Sit-In Highlights Laid-Off Workers, Employers Obligations, and WARN Act, According to Outten & Golden LLP
10. Golden Meditech Brings in Financial Investor Through New Share Issuance
11. Golden Meditech Releases FY2008/09 Interim Results
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... share medical images have been lifted as IMAGE Information Systems launches MED-TAB™ -- ... of North America Annual Meeting from November 29 to December 4, 2015. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays ... film for accurate interpretation by the radiologist. The marking utensils are so small, ... Calif., has found a way to alleviate this problem. , He developed the ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... Burlington, MA (PRWEB) , ... December 01, 2015 , ... ... the release of Clarity, the latest addition to the devices for sale in the ... technologies, 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 - CES, Las Vegas, ... Las Vegas for CES 2016, the world’s largest Consumer Electronic Show, where they will ... Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 ... ) has announced the addition of ... Testing Market: Campylobacter, Cryptosporidium, E. Coli, ... Yersinia" report to their offering. ... announced the addition of the ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... --  Craneware, Inc ., the healthcare market leader ... company will showcase a new version of its ... at the American Society for Health-System Pharmacists (ASHP) ... features are focused on simplifying and streamlining the ... pharmacy charges to ensure compliance and optimal revenue ...
Breaking Medicine Technology: